newsfilter
← Latest News
PR Newswire·

Large Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide

-- One of the Largest Commercial Payers in the U.S. Expands Access to Phexxi® for Women Seeking FDA-Approved, Hormone-Free Contraception -- SAN DIEGO, Sept. 16, 2022 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCPK: EVFM) today announced another new i